# Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention

> **NCT03473613** · PHASE3 · COMPLETED · sponsor: **Benha University** · enrollment: 230 (actual)

## Conditions studied

- Ovarian Hyperstimulation

## Interventions

- **DRUG:** Oral Cabergoline
- **DRUG:** Calcium Gluconate

## Key facts

- **NCT ID:** NCT03473613
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-01
- **Primary completion:** 2017-04-15
- **Final completion:** 2017-04-15
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03473613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03473613, "Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03473613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*